Income Statement (IVERIC/BIO)

Technical Analysis Historical Data Financials News & Analysis

IVERIC/BIO NEWS

Clearside Biomedical Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update By Site Author - 1 month ago

- Successful End-of-Phase 2 Meeting with FDA Results in Alignment on Phase 3 Plans for CLS-AX in Wet AMD - - Asia-Pacific Partners New Drug Application for ARCATUS®(XIPERE®) for Uveitic Macular Edem… [+16915 chars]...

Read more
Top Stock
CurrencyPrice Chg
BA 		182.05 -0.25
-0.14%
CVX 		139.55 -0.55
-0.39%
CAT 		307.62 0.56
0.18%
INTC 		20.59 0.08
0.37%
MSFT 		394.08 2.92
0.75%
DIS 		91.51 1.35
1.5%
DOW 		30.49 0.54
1.79%
CSCO 		57.41 0.57
1%
GS 		550.01 3.61
0.66%